Mark Aagren

Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes

Reactive Oxygen Species in Inflammation and Tissue Injury

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

The Economic Costs of Type 2 Diabetes: A Global Systematic Review

Complementing Insulin Therapy to Achieve Glycemic Control

Mechanisms of diabetes mellitus-induced bone fragility

Sarcopenia: a chronic complication of type 2 diabetes mellitus

Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects

Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney Disease

Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database

The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern

Type 2 diabetes

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

Discrepancy between Results and Abstract Conclusions in Industry- vs Nonindustry-funded Studies Comparing Topical Prostaglandins

Type 2 diabetes mellitus

Industry sponsorship and research outcome

Chronic Kidney Disease Diagnosis and Management

Artificial Intelligence in Surgery: Promises and Perils

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Real‐world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia

Usability Evaluation of a Blood Glucose Monitoring System With a Spill-Resistant Vial, Easier Strip Handling, and Connectivity to a Mobile App

The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Pen Devices for Insulin Self-Administration Compared With Needle and Vial

Second-Generation Difluorinated Cyclooctynes for Copper-Free Click Chemistry

Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

Industry sponsorship and research outcome

Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles

A New Synthetic Approach to High‐Purity (15R)‐Latanoprost

Assessment of adherence and healthcare costs of insulin device (FlexPen®) versus conventional vial/syringe

Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods

Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma

Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin

Direct Health Care Costs of Patients With Type 2 Diabetes Within a Privately Insured Employed Population, 2000 and 2005

Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials

Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes

Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes